Investigating how specific proteins affect heart disease development

Role of ROCK isoform-mediated actin cytoskeleton modification in the pathogenesis of heart disease

['FUNDING_R01'] · INDIANA UNIVERSITY INDIANAPOLIS · NIH-10762336

This study is looking at how two specific proteins, ROCK1 and ROCK2, affect heart cells and their function, which could help us find new ways to treat heart disease.

Quick facts

Phase['FUNDING_R01']
Study typeNih_funding
SexAll
SponsorINDIANA UNIVERSITY INDIANAPOLIS (nih funded)
Locations1 site (INDIANAPOLIS, UNITED STATES)
Trial IDNIH-10762336 on ClinicalTrials.gov

What this research studies

This research focuses on understanding the role of Rho kinase (ROCK) proteins in heart disease, particularly how they influence the structure and function of heart cells. By studying the two types of ROCK proteins, ROCK1 and ROCK2, the research aims to uncover their distinct and shared roles in regulating the actin cytoskeleton, which is crucial for heart function. The researchers will use advanced techniques to manipulate these proteins in heart cells to see how changes affect heart health and disease progression. This could lead to new therapeutic strategies for treating heart conditions.

Who could benefit from this research

Good fit: Ideal candidates for this research are adults aged 21 and older who are at risk for or currently experiencing cardiovascular diseases.

Not a fit: Patients with non-cardiovascular diseases or those under 21 years old may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that improve heart function and reduce the risk of heart disease.

How similar studies have performed: Previous research has shown that targeting ROCK proteins can be beneficial in other cardiovascular studies, suggesting a promising avenue for this investigation.

Where this research is happening

INDIANAPOLIS, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Conditions: cardiovascular disorder, Cardiovascular Diseases

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.